EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Longitudinal Peripheral Immunophenotyping and Rituximab Response in Primary Membranous Nephropathy: A Prospective Cohort Study

Christos Georgopoulos iD, Lefkothea Dova, Eleni Stamellou, Anila Duni, Georgios Vartholomatos iD, George Liapis, Vasileios Patsiogiannis, Ekaterini Siomou iD, Haralampos Milionis iD, Evangelia Dounousi iD

International Journal of Molecular Sciences · 06.11.2026 · 27 (21) · 9956

DOI: 10.3390/ijms27219956 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.11.2026. Verfasst von Christos Georgopoulos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, University of Ioannina and University Hospital of Ioannina, Stavrou Niarchou Avenue, 45500 Ioannina, Greece. Hauptthemen laut MEDLINE: Rituximab, Glomerulonephritis, Membranous, Immunophenotyping, Immunologic Factors. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rituximab (RTX) is a first-line option for primary membranous nephropathy (pMN), but many patients fail to respond for reasons that conventional markers only partially explain. We assessed whether longitudinal peripheral immunophenotyping could identify cellular biomarkers of response. In a prospective single-center cohort of 35 patients with pMN treated with standard two-dose RTX, flow cytometry of B-cell, T-cell and monocyte compartments, the systemic inflammation response index (SIRI) and phospholipase A2 receptor antibody were assessed at baseline and months 3, 6 and 12. Within a mean of 7.48 ± 2.4 months, 23 patients (65.7%) achieved either partial or complete remission. By month three, responders showed deeper B-cell depletion, higher CD4+CD25+FoxP3+ T cells, fewer intermediate monocytes and a lower SIRI. On multivariate analysis, month-3 depletion of total CD3−CD19+ B cells below 0.5% (odds ratio 5.8, 95% confidence interval 1.1–31.1) was associated with remission, and each 0.1-unit increase in month-3 SIRI (odds ratio 0.44, 95% confidence interval 0.22–0.91) with lower odds of remission. In a hypothesis-generating analysis, a model combining both had an apparent area under the curve of 0.87. Longitudinal immunophenotyping identifies candidate biomarkers of RTX response in pMN that require multicenter validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RituximabGlomerulonephritis, MembranousImmunophenotypingImmunologic FactorsHumansFemaleMaleProspective StudiesMiddle AgedBiomarkersB-LymphocytesAdultTreatment OutcomeT-LymphocytesAgedFlow Cytometry

Stichwörter der Autor:innen

B-lymphocytesbiomarkersflow cytometryglomerulonephritismembranousrituximab

Substanzen

RituximabBiomarkersImmunologic Factors

Autor:innen und Institutionen

  • Department of Nephrology, University of Ioannina and University Hospital of Ioannina, Stavrou Niarchou Avenue, 45500 Ioannina, Greece.
  • Laboratory of Hematology-Unit of Molecular Biology, University Hospital of Ioannina, 45500 Ioannina, Greece.
  • First Pathology Laboratory, General Hospital of Athens "Laiko″, 11527 Athens, Greece.
  • Department of Radiology, University Hospital of Ioannina, 45500 Ioannina, Greece.
  • Department of Pediatrics, University Hospital of Ioannina, 45500 Ioannina, Greece.
  • First Department of Internal Medicine, University Hospital of Ioannina, 45500 Ioannina, Greece.

ORCID-Profile: Christos Georgopoulos, Georgios Vartholomatos, Ekaterini Siomou, Haralampos Milionis, Evangelia Dounousi

Zitieren

APA

Georgopoulos, C., Dova, L., Stamellou, E., Duni, A., Vartholomatos, G., Liapis, G., Patsiogiannis, V., Siomou, E., Milionis, H., & Dounousi, E. (2026). Longitudinal Peripheral Immunophenotyping and Rituximab Response in Primary Membranous Nephropathy: A Prospective Cohort Study. International Journal of Molecular Sciences, 27(21), 9956. https://doi.org/10.3390/ijms27219956

Vancouver

Georgopoulos C, Dova L, Stamellou E, Duni A, Vartholomatos G, Liapis G, et al. Longitudinal Peripheral Immunophenotyping and Rituximab Response in Primary Membranous Nephropathy: A Prospective Cohort Study. International Journal of Molecular Sciences. 2026;27(21):9956. doi:10.3390/ijms27219956

BibTeX
@article{Georgopoulos2026,
  author = {Georgopoulos, Christos and Dova, Lefkothea and Stamellou, Eleni and Duni, Anila and Vartholomatos, Georgios and Liapis, George and Patsiogiannis, Vasileios and Siomou, Ekaterini and Milionis, Haralampos and Dounousi, Evangelia},
  title = {Longitudinal Peripheral Immunophenotyping and Rituximab Response in Primary Membranous Nephropathy: A Prospective Cohort Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9956},
  doi = {10.3390/ijms27219956}
}
Kostenlos starten →